Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, announced the publication of a peer-reviewed manuscript regarding a new protocol for automated expansion of HEK293T cells that are used to produce the viral vectors powering cell and gene therapies. The accepted manuscript, published .
Opportunity Emerges for Improved Vaccine Design miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Study proposes new bioinformatic approach to design better vaccines medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
A new paper in Biology Methods & Protocols shows it may be possible to design vaccines that will induce a stronger immune response to infecting pathogens, such as the virus causing COVID-19. In this study, the authors proposed and tested a new bioinformatic approach and tool that allows researchers to select parts of proteins that will elicit a strong immune response. Vaccines developed based on this approach would provide better protection from diseases.
A new paper in Biology Methods & Protocols, published by Oxford University Press, shows it may be possible to design vaccines that will induce a stronger immune response to infecting pathogens, such as the virus causing COVID-19.